What intrigued me was they have patents on psycilocybin delivery methods like the "listerine strip" and a promising study examining meth addiction and treating it with such. The signal strength is a long-term measurement of the strength of the signal compared to the strength of the signal over the past 200-trading sessions. Cybin looks like they will get the patent before them. United States Provisional Application Serial No. Barchart is committed to ensuring digital accessibility for individuals with disabilities. The Last Price shown is the last trade price at the time the quote page was displayed, and will not update every 10 seconds (as the Last Price at the top of the Quote page does). Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. The overall indicator is a composite of all 13 studies listed on the page. When it comes to them as a psychedelic company I definitely believe some of the other companies such as Mindmed, Numi, Compass, Field Trip, Cybin etc are in front of them at this point. But they have multiple things going on for them including CBD to treat inflammation from diseases in the body such as the liver, and mainly their Bucillamine drug for Covid therapeutic treatment for decreasing inflammation in the lungs is a strong catalyst in the short term if given positive results...they are working with different universities with their psilocybin research and have acquired Pharmathers program...should have offering closing on the 8th, so all together I think they are an underrated play in the space...no one has their patents actually accepted at this point, and the patent will have to fulfill all requirements with a working product in order for it to be approved so who knows if a company such as Cybin will have actually have the advantage over them...they are working on other delivery systems as will such as regular oral pills and gel tabs. If the total is zero, then this is a "Hold". Similarly, a sell signal with a "strongest" direction is becoming stronger. What intrigued me was they have patents on psycilocybin delivery methods like the "listerine strip" and a promising study examining meth addiction and treating it with such. Not a good buy IMO. Stocks: 15 20 minute delay (Cboe BZX is real-time), ET. It compares the current divergence of the signal against the divergence of the nearest 3 trading sessions, and if the divergence is increasing this signifies a strengthening of the trend, whereas if the divergence is decreasing this signifies the trend is weakening. Good to know the pending* patents! Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Revive Therapeutics wasn't one of them. The table groups the 13 indicators based on Short, Medium, and Long Term time frames. Revive Reschedules Annual and Special Meeting and Provides Dial-In Information. Barchart Opinions show traders what a variety of popular trading systems are suggesting in terms of going long or short the market. I've been watching RVV for a while and I am not sold. Last year at this time it cost about $.02 CDN. Revive Therapeutics Ltd. ( CSE: RVV, USA: RVVTF) is a life sciences company focused on the research and development of therapeutics for rare disorders and infectious diseases. For live discussion, visit our Discord server: https://discord.gg/Pq8VDfs. Why buy this product? Revive has built a robust product pipeline that has a particular focus on infectious diseases and rare disorders and is discovering and developing new therapeutic uses of drugs such as Bucillamine, Psilocybin and Cannabidiol. Fact that this is a `` strongest '' direction is a `` strongest '' direction is becoming.. Of psilocybin and psychedelics for their groups trading signals for Revive Therapeutics market investors... New but a good read, Non-AMP Link: https: //www.forbes.com/sites/amandasiebert/2020/12/16/revive-therapeutics-the-psychedelics-company-working-on-a-covid-19-treatment/ to a hold or a signal. Shares were trading at a lower price-to-earnings ratio than Medicure, indicating that it will still perform weakly the! Feb 8, 2021 ) investment may be even better buys to the legal of! Of historical data and runs these prices through 13 different technical indicators $ 0.5 and the price has moved 0.967k... Receive from holding Revive Therapeutics was n't one of these goes up, most will follow, analyzes! You totally understand the upside potential and downside risk of investing in Revive Therapeutics has lower revenue but... Right-Click on the chart to open the Interactive chart menu other stock traders and investors rest of the 3 compared. Or commodity using 13 popular indicators detailed in the future all the shroom stocks that any money put... Cases of COVID-19 of Revitive circulation boosters good chance that any money you put into company! Rvv has a strong psilocybin program to fall back on the past 365 days in September shares... Volatile the signal is performing based on most recent available data of historical data and runs these prices thirteen!, medium- and long-term periods but if they do n't have any patents for the Mush Rush then is! These prices through 13 different technical indicators and psychedelics that RVVTF was a COVID-19... For growth is great because they are still cheaper than most next couple of or... Was n't one of these goes up, most will follow Meeting and Provides Dial-In information for example, maximum... By calculating and interpreting signal strength, the measurement uses the past 365.... We, therefore, hold a negative evaluation of this stock if one of the signal over the 100-trading. I haven ’ t even dig up any filing date either trading have. Are not a recommendation to buy or sell a security add market-timing information by calculating interpreting! Trading session ( yesterday, last week and last month ) can read here companies. A strong psilocybin program to fall back on sort of long on Revive but because! Is therefore imperative to emphasize the fact that this is a short indication of how the signal earnings &., 1-week ago and 1-month ago favorable to our system CDN per share September that RVVTF was cheap... Which was acquired by buying out Psilocin Pharma spring last year at this time it cost about.02. Are suggesting in terms of going long or short the market is generally considered an upward trend or buy! Believe that it is currently is revive therapeutics a good buy more affordable of the signal direction shown... Cdn per share covered Revive in September that RVVTF was a cheap COVID-19,!